Finance

Lists
Q1 2027 earnings • released • EPS beat +4.94% • Revenue miss -38.36%
See results
ROIV:NASDAQ
Roivant Sciences Ltd
$35.88
-1.27%
(-0.46) 1D
Aug 10, 12:31:25 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ROIV...
Open
$36.05
High
$36.78
Low
$35.88
Mkt. cap
25.96B
Avg. vol.
5.34M
Volume
2.89M
52-wk high
$37.00
52-wk low
$10.90
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
Open
$36.05
High
$36.78
Low
$35.88
Mkt. cap
25.96B
Avg. vol.
5.34M
Volume
2.89M
52-wk high
$37.00
52-wk low
$10.90
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
News stories
From sources across the web
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd
CEOMatt Gline
Employees721
FoundedApr 7, 2014
Headquarters-
SectorBiotechnology
Websiteroivant.com
Analyst ratings
Based on 7 analysts giving stock ratings to ROIV in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ROIV in the last 3 months.
Highest
Current $35.88
$50.00 (+39.35%)
Average
$42.29 (+17.87%)
Lowest
$37.00 (+3.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Buy
Maintained
$40.00
+11.5%
08/10/2026
Samantha Semenkow
Citi
Buy
Maintained
$46.00
+28.2%
08/10/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$40.00
+11.5%
08/07/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$42.00
+17.1%
08/07/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$41.00
+14.3%
08/07/2026
Chi Meng Fong
Bank of America Securities
Hold
Reiterated
$37.00
+3.1%
08/07/2026
Yaron Werber
TD Cowen
Buy
Maintained
$50.00
+39.4%
08/06/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$40.00
+11.5%
04/16/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
$41.00
+14.3%
04/15/2026
William Pickering
Bernstein
Buy
Initiated
$35.00
-2.5%
03/20/2026
Dennis Ding
Jefferies
Buy
Maintained
$30.00
-16.4%
02/09/2026
Last report
Aug 6, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
-$0.34 / -$0.36
+4.94%beat
Revenue / Est. (USD)
1.44M / 2.34M
-38.36%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.57M
2.00M
2.52M
1.44M
Cost of goods sold
164.18M
166.08M
199.26M
202.30M
Cost of revenue
164.18M
166.08M
199.26M
202.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.52M
175.05M
173.07M
165.53M
Operating expense
129.52M
175.05M
173.07M
165.53M
Total operating expenses
293.70M
341.13M
372.33M
367.83M
Operating income
-292.13M
-339.14M
-369.81M
-366.38M
Other non operating income
-26.65M
-16.07M
12.57M
-2.93M
EBT including unusual items
-159.04M
-290.37M
454.10M
-294.56M
EBT excluding unusual items
-273.44M
-311.94M
-316.06M
-331.59M
Income tax expense
7.00M
23.33M
98.35M
-3.96M
Effective tax rate
-4.40%
-8.04%
21.66%
1.34%
Other operating expenses
-
-
-
-
Net income
-113.52M
-265.89M
302.99M
-189.84M
Net profit margin
-7,225.91%
-13,301.20%
12,023.57%
-13,164.84%
Earnings per share
-0.28
-0.24
-0.32
-0.34
Interest and investment income
45.34M
43.27M
41.18M
36.92M
Interest expense
-
-
-
-
Net interest expenses
45.34M
43.27M
41.18M
36.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
-291.21M
-338.44M
-369.17M
-365.78M
Gain or loss from assets sale
-
-
-11.03M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps